SpectraCure raises approximately SEK 140 million through a fully subscribed rights issue
SpectraCure AB’s (publ) (Nasdaq First North Premier Growth Market: SPEC) (“SpectraCure” or the “Company”) fully guaranteed new Units issue with preferential rights for the Company’s existing shareholders (the “Rights Issue”), was fully subscribed. Through the Rights Issue, SpectraCure will receive proceeds amounting to approximately SEK 140 million before transaction costs. Not for publication, distribution or […]
Subscription period postponed for the rights issue. Other conditions remain unchanged
SpectraCure AB (publ) postpones the subscription period for the rights issue which was announced on 5 May 2020. The new subscription period is between Friday, 5 June 2020 and Tuesday, 23 June 2020 inclusive. All other terms and conditions of the rights issue remain unchanged. The Board of Directors of SpectraCure AB (publ) has resolved to postpone […]
SpectraCure’s MSEK 140 rights issue of units is fully guaranteed
THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, JAPAN, CANADA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER ACTION. A top guarantee up to 100 percent of the rights issue has been […]
Exercise rate of 98.8 percent for SpectraCure’s warrants (TO3)
On 29 November, SpectraCure AB (publ) (“SpectraCure”) ended the exercise period for the Series 3 TO3 B subscription warrants. In total, 5,828,739 shares have been subscribed during the now concluded exercise period. SpectraCure is thus provided MSEK 37.9 in proceeds, before issuance costs to the estimated amount of MSEK 1.1. The exercise rate was 98.8 percent. As […]
Last day of trading of SPEC TO3 subscription warrants tomorrow, Nov. 27
The last day of trading of SpectraCure AB (publ) TO3 is Wednesday, November 27th, 2019. Subscription of shares supported by the warrants in the TO3 program, implies that every two (2) warrants entitles the holder to subscribe for one (1) new share in SpectraCure at the subscription price of SEK 6.50. If all warrants are fully […]
SpectraCure´s main owner subscribes in full for his share
SpectraCure's main owner and CEO Masoud Khayyami subscribes in full through his company Cardeon Futuring Finance his share in the company's warrants program TO3, corresponding to 1 653 382 warrants. Cardeon Futuring Finance's total holding in SpectraCure after the issue amounts to 2 480 073 shares. Prior to the acquisition Masoud Khayyami, privately and with companies […]
The first day of trading with warrants of series TO2 is estimated at 27 January 2017
The first day of trading in the newly issued shares was 23 January 2017 and the first day of trading of series TO 2 warrants is expected to be Friday, January 27, 2017. After registration of the issue, the number of shares amounts to 56 591 520 and the number of warrants to 26 604 […]
SpectraCure decides on Set-off Issue
The Board of Directors has, on the basis of authorization at the annual general meeting (AGM) on 18 May 2016, decided to issue 2 493 780 units at the same rate as in the recently completed rights issue (0.80 SEK) for compensation equivalent to SEK 1 995 024 to advisors in accordance with contract. The […]
